AndreaBozzo/ceres-open-data-index huggingface dataset:
Business Rules PUF - PY2021

The Business Rules PUF (BR-PUF) is one of the files that make up the Marketplace PUF. The BR-PUF contains plan-level data on the application of rates, such as allowed relationships (e.g., spouse, dependents) and tobacco use. These data either originate from the Business Rules template (i.e., template field), an Excel-based form used by issuers to describe their plans in the QHP/SADP application process, or were generated by CCIIO for use in data processing (i.e., system-generated).
2011 CMHS Uniform Reporting System (URS) Output Tables for Maine

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2011. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 528961: Phenol, 2-(1-propylpentyl)-6-nitro

Chemical compound data from PubChem database. IUPAC Name: 2-nitro-6-octan-4-ylphenol. Molecular Formula: C14H21NO3. Molecular Weight: 251.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
AFCARS Report #18

This report provides preliminary estimaes of AFCARS data for FY 2010. Preliminary reports of AFCARS data include data received by September 30 for the report period ending March 31 and by March 31 for the report period ending September 30. This generally encompasses the required data submissions and submission of corrected data by States to avoid possible financial penalties.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 529470: 2,2,2-trifluoro-N-(1-phenylethyl)acetamide

Chemical compound data from PubChem database. IUPAC Name: 2,2,2-trifluoro-N-(1-phenylethyl)acetamide. Molecular Formula: C10H10F3NO. Molecular Weight: 217.19. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - Table II. Cryptosporidiosis to Dengue

NNDSS - Table II. Cryptosporidiosis to Dengue - 2017.  In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories.

Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. 

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. 

Footnotes:
 C.N.M.I.: Commonwealth of Northern Mariana Islands. 

U: Unavailable. —: No reported cases. N: Not reportable. NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. 

* Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions. 

† Case counts for reporting year 2017 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for tuberculosis are displayed in Table IV, which appears quarterly.

§ Includes data for dengue and dengue-like illness.
Compound 528735: Noradrenaline, DTFMB-TMS

Chemical compound data from PubChem database. IUPAC Name: N-[2-[3,4-bis(trimethylsilyloxy)phenyl]-2-trimethylsilyloxyethyl]-3,5-bis(trifluoromethyl)benzamide. Molecular Formula: C26H37F6NO4Si3. Molecular Weight: 625.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400754-T1: [Translated] MECHANICAL SEAL AND METHOD FOR MOUNTING A MECHANICAL SEAL

The seal has a non-rotating slide ring (105) formed as a cylinder having a variable inner diameter that defines a profile (115) forming a cross-section of the slide ring and corresponding to a matching profile of a rotatable shaft (101) for engagement. Independent claims are included for the following (A) a method of mounting a slide ring of slide ring seal on rotatable shaft; and (B) a vacuum pump.
Compound 525715: (p-Methylbenzylidene)-(3-methylphenyl)-amine

Chemical compound data from PubChem database. IUPAC Name: N-(3-methylphenyl)-1-(4-methylphenyl)methanimine. Molecular Formula: C15H15N. Molecular Weight: 209.29. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Managed Care Individual Provider Network Data: June 30, 2015

The primary purpose for the Provider Network Data System is to collect data needed to evaluate the provider networks including physicians, hospitals, labs, home health agencies, durable medical equipment providers, etc., for all types of Managed Care plans in New York State, including HIV Special Need Plans (SNP), Family Health Plus (FHP) Buy-In, Programs of All-Inclusive Care for the Elderly (PACE), and Non-PACE Managed Long-Term Care (MLTC) plans. This dataset reflects individual provider data. Provider Network Data System information is self-reported. For more information, check out http://www.health.ny.gov/health_care/managed_care/.
Patent AT-E399619-T1: [Translated] BELT GRINDING MACHINE, PREFERABLY FOR COMBINATION WITH AN ATTACHMENT FOR GRINDING TUBE ENDS

The belt grinding machine (100) is combined with an attachment (200), e.g. for grinding tube ends. Rollers of several different diameters are available, so that the endless grinding belt can be laid out selectively as required. There is a band tension adjustment device which is optimized mechanically independently of the diameter of the contact roller.
Compound 528806: [3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] dodecanoate

Chemical compound data from PubChem database. IUPAC Name: [3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] dodecanoate. Molecular Formula: C32H52O2. Molecular Weight: 468.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
MEDLINE/PubMed Citations

PubMed is a free resource supporting the search and retrieval of biomedical and life sciences literature with the aim of improving health–both globally and personally.

The PubMed database contains citations and abstracts of biomedical literature. It does not include full text journal articles; however, links to the full text are often present when available from other sources, such as the publisher's website or PubMed Central (PMC). 

See the PubMed User Guide for more information. https://pubmed.ncbi.nlm.nih.gov/help/
Youths in Therapeutic Foster Care at Elevated Risk for Substance Use (2002 to 2010 NSDUH)

This report uses 2002 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past month binge alcohol use, marijuana use, and nonmedical use of prescription-type psychotherapeutics among adolescents aged 12 to 17 by whether they had been in therapeutic foster care or traditional foster care.
Managed Care Individual Provider Network Data: December 31, 2015

The primary purpose for the Provider Network Data System is to collect data needed to evaluate the provider networks including physicians, hospitals, labs, home health agencies, durable medical equipment providers, etc., for all types of Managed Care plans in New York State, including HIV Special Need Plans (SNP), Family Health Plus (FHP) Buy-In, Programs of All-Inclusive Care for the Elderly (PACE), and Non-PACE Managed Long-Term Care (MLTC) plans. This dataset reflects individual provider data. Provider Network Data System information is self-reported. For more information, check out http://www.health.ny.gov/health_care/managed_care/.
Adoption Data 2007

This page includes reports on state-specific adoption statistics for fiscal year 2007.

Receiving Adoption Subsidy: 10/1/2006 - 9/30/2007
Adoptive Family Structure: 10/1/2006 - 9/30/2007
Age at Adoption Finalization: 10/1/2006 - 9/30/2007
Prior Relationship of Adoptive Parent(s) to Child: 10/1/2006 - 9/30/2007
Race/Ethnicity of Public Agency Children Adopted: 10/1/2006 - 9/30/2007
Sex of Public Agency Children Adopted: 10/1/2006 - 9/30/2007
Child is Identified as a Special Needs Adoption: 10/1/2006 - 9/30/2007
Time between Termination of Parental Rights (TPR) and Adoption Finalization: 10/1/2006 - 9/30/2007

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 528722: Pyridine, 5-ethyl-2,4-dimethyl

Chemical compound data from PubChem database. IUPAC Name: 5-ethyl-2,4-dimethylpyridine. Molecular Formula: C9H13N. Molecular Weight: 135.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Information Memorandum (IM-93-19)

This Information Memorandum (IM) establishes Fiscal Year (FY) 1993 Allotments for Title IV-B and Procedures for Applying for: (1) Funds Representing the Difference Between What a State Has Been Awarded and Its Full Share of Funds Available Under Title IV-B in FY 1992; and (2) Realloted IV-B Funds.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E399982-T1: [Translated] METERING VALVE AND USE OF A VARIETY OF THEM

The dosing valve has a collection chamber (11) which is varied in volume by actuating the membrane (16), and which discharges into a valve output line (8). Enlarging the volume induces fluid by suction from the valve input line (7) only. Reducing the volume closes the first non return valve (13). The dosing piston (20) and membrane are operated together for discharge.
COVID-19 State Profile Report - Minnesota

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
2017 National Directory of Drug and Alcohol  Abuse Treatment Facilities

The National Directory of Drug and Alcohol Abuse Treatment Facilities - 2017 is a listing of federal, state, and local government facilities and private facilities that provide substance abuse treatment services. It includes treatment facilities that (1) are licensed, certified, or otherwise approved for inclusion in the Directory by their State Substance Abuse Agencies, and (2) responded to the 2016 National Survey of Substance Abuse Treatment Services (N-SSATS). The information about each facility that appears in this Directory was provided by that facility in response to the 2016 N-SSATS. N-SSATS is conducted annually by the Substance Abuse and Mental Health Services Administration (SAMHSA).The Directory is ordered alphabetically by state, by city within each state, and by facility name within each city. Each facility listing includes codes that represent the services offered and other features of the facility, including codes that indicate services for hearing impaired and non-English-speaking clients. Codes are defined in a key shown on pages v-vii. Because the services offered by a particular facility may change over time, it is always a good idea to verify the information in this Directory when contacting a facility.
Research Article: Current Controlled Trials in Cardiovascular Medicine

Some problems with the quality of controlled clinical trials can be addressed by following these procedures: registering all trials at inception; using systematic reviews to inform the design of new studies; posting and obtaining feedback on preprints; reporting all well conducted trials, regardless of their results; reducing biased and inefficient assessment of reports submitted for publication; publishing sufficiently detailed reports; linking trial reports to relevant external information; providing readier access to reports; and reviewing and amending reports after initial publication. The launch of a new range of electronic journals by Current Controlled Trials offers an opportunity to contribute to progress in these ways.
Compound 526347: 3,4,6-Tribromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 3,4,6-tribromodibenzofuran. Molecular Formula: C12H5Br3O. Molecular Weight: 404.88. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Reconstitution of licensed replication origins on

Background
          In order to ensure precise chromosome duplication, eukaryotes "license" their replication origins during late mitosis and early G1 by assembling complexes of Mcm2-7 onto them. Mcm2-7 are essential for DNA replication, but are displaced from origins as they initiate, thus ensuring that no origin fires more than once in a single cell cycle.
        
        
          Results
          Here we show that a combination of purified nucleoplasmin, the origin recognition complex (ORC), Cdc6, RLF-B/Cdt1 and Mcm2-7 can promote functional origin licensing and the assembly of Mcm2-7 onto Xenopus sperm nuclei. The reconstituted reaction is inhibited by geminin, a specific RLF-B/Cdt1 inhibitor. Interestingly, the purified ORC used in the reconstitution had apparently lost the Orc6 subunit, suggesting that Orc6 is not essential for replication licensing. We use the reconstituted system to make a preliminary analysis of the different events occuring during origin assembly, and examine their nucleotide requirements. We show that the loading of Xenopus ORC onto chromatin is strongly stimulated by both ADP, ATP and ATP-γ-S whilst the loading of Cdc6 and Cdt1 is stimulated only by ATP or ATP-γ-S.
        
        
          Conclusions
          Nucleoplasmin, ORC, Cdc6, RLF-B/Cdt1 and Mcm2-7 are the only proteins required for functional licensing and the loading of Mcm2-7 onto chromatin. The requirement for nucleoplasmin probably only reflects a requirement to decondense sperm chromatin before ORC can bind to it. Use of this reconstituted system should allow a full biochemical analysis of origin licensing and Mcm2-7 loading.
Managing Clinician Aggregation Group Performance

The Managing Clinician Aggregation Group Performance dataset provides performance information in the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model. The dataset includes information on Performance Payment Adjustment (PPA), Modality Performance Score (MPS), home dialysis rate, and transplant rate, as well as the individual components of each rate for each model participant Managing Clinician aggregation group.

 

All Managing Clinicians within the same aggregation group share the same performance information. The supplementary aggregation group crosswalk file may be used to map aggregation groups to individual ETC Participant Managing Clinicians.
Compound 530204: Octadecane, 9-methyl-8-propyl

Chemical compound data from PubChem database. IUPAC Name: 9-methyl-8-propyloctadecane. Molecular Formula: C22H46. Molecular Weight: 310.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401665-T1: [Translated] METHOD FOR SELF-ALIGNING A DAMASCEN GATE STRUCTURE TO ISOLATION AREAS

A process for fabricating a CMOS device in which conductive gate structures are defined self-aligned to shallow trench isolation (STI), regions, without using a photolithographic procedure, has been developed. The process features definition of shallow trench openings in regions of a semiconductor substrate not covered by dummy gate structures, or by silicon oxide spacers located on sides of the dummy gate structures. Filling of the shallow trench openings with silicon oxide, and removal of the dummy gate structures, result in STI regions comprised of filled shallow trench openings, overlying silicon oxide shapes, and silicon oxide sidewall spacers on the sides of the overlying silicon oxide shapes. Formation of silicon nitride spacers on the sides of the STI regions, is followed by deposition of a high k gate insulator layer and of a conductive gate structure, with the conductive gate structure formed self-aligned to the STI regions. <IMAGE>
Compound 526315: 2,3,4,8-Tetrabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 2,3,4,8-tetrabromodibenzofuran. Molecular Formula: C12H4Br4O. Molecular Weight: 483.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Associations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the United States

This CBHSQ data review uses 2002 through 2011 National Survey on Drug Use and Health (NSDUH) data to examine recent trends in heroin initiation, including the role of nonmedical prescription pain reliever use in the heroin trend among persons aged 12 to 49. Data are presented for various age groups, gender, race/ethnicity, household income, county type, and region.
Mpox Cases Over Time

<strong>A. SUMMARY</strong>
This dataset represents probable or confirmed mpox cases among San Francisco residents. Cases are included by the episode date, defined as either the date when self-reported symptoms began or, if that date is not available, the date the positive test was collected (i.e., specimen collection date). 

Data are lagged by 5 days, meaning that the most recent date of self-reported symptom or specimen collection included is 1 day prior to today. All data update daily as more information becomes available. 

<strong>B. HOW THE DATASET IS CREATED</strong>
Case information is based on confirmed or probable positive laboratory tests reported to the San Francisco Department of Public Health. Processes to provide quality assurance and other data verification are completed before the data are reported. 

This data may not be immediately available for recently reported cases because of the time needed to process tests and validate cases. 

Data are continually updated to maximize completeness of information and reporting on San Francisco residents with confirmed or probable mpox.

<strong>C. UPDATE PROCESS</strong>
Updates to the data are made through automated and manual processes once each day, Monday through Friday.  

<strong>D. HOW TO USE THIS DATASET</strong>
This dataset shows new cases and cumulative cases (probable and confirmed) by episode date. Episode date is the date of self-reported symptom onset, or, if not available, date of specimen collection (i.e., the date the person was tested). 

New cases are the count of cases with a symptom onset or specimen collection date on the given episode date. Cumulative cases are the running total of all San Francisco cases through the episode date listed.

<strong>D. CHANGE LOG</strong>
6/15/2023 - added "data_updated_at" column to reference the last date the data was compiled by scripts.
Patent AT-E400465-T1: [Translated] BELT TENSION INDICATOR

A tension detector has a flexible strap ( 350 ) having its end stitched into a loop ( 352 ) that wraps round a central shaft ( 354 ). A U-shaped one-piece coil spring has two coiled end portions ( 356 ) and ( 358 ) wrapped round the shaft ( 354 ). The end portions ( 356 ) and ( 358 ) are inter-connected by a central stirrup ( 360 ). A tether strap ( 316 ) has a loop ( 362 ) sewn into its end which engages round the stirrup ( 360 ). The ends of the shaft ( 354 ) are journalled in side walls of a housing ( 366 ). Each side wall has an inwardly direct abutment projection ( 368 ). The upper surface of the housing ( 366 ) includes a window ( 370 ) through which an arcuate indicator ( 372 ) is visible. The indicator ( 372 ) has side legs ( 374 ) and ( 376 ) that are slidably mounted on the stirrup ( 360 ). When the strap ( 316 ) is relaxed, the left hand end of the arcuate indicator ( 372 ) is visible through the window ( 370 ). When the strap ( 316 ) is tightened, the arcuate indicator ( 372 ) pivots to the position shown in <FIGREF IDREF="DRAWINGS">FIG. 11</FIGREF> in which its right hand end, which is of a different color to its left hand end, is visible through the window ( 370 ), indicating that the strap ( 316 ) has been tightened adequately. In the event of a crash, the coiled end portions ( 356 ) and ( 358 ) of the spring over-ride the abutment projections ( 368 ) and partially unwrap from the shaft ( 354 ) so that an extended stirrup portion ( 360 ) projects from the housing ( 366 ).
Patent AT-E400628-T1: [Translated] METHOD FOR INTRODUCING A CATALYST INTO A REACTOR SUITABLE FOR HETEROGENEOUS PHASE REACTIONS

Process for the charging of a catalyst and for the running of a reactor in which reactions take place in multiphase systems, wherein a gaseous phase prevalently consisting of CO and H 2  is bubbled into a suspension of a solid in the form of particles (catalyst) in a liquid (prevalently reaction product), according to the Fischer-Tropsch technology.